Detection of ATTR aggregates in the plasma of polyneuropathic patients with ATTR-V30M amyloidosis.
作者信息
Pedretti Rose, Wang Lanie, Grodin Justin L, Masri Ahmad, Kelly Jeffery, Saelices Lorena
机构信息
Department of Biophysics, Peter O'Donnell Jr. Brain Institute, Center for Alzheimer's and Neurodegenerative Diseases, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Department of Internal Medicine, Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
出版信息
Amyloid. 2024 Dec;31(4):350-352. doi: 10.1080/13506129.2024.2404073. Epub 2024 Sep 16.
Abstract
摘要
相似文献
1
Detection of ATTR aggregates in the plasma of polyneuropathic patients with ATTR-V30M amyloidosis.
Amyloid. 2024 Dec;31(4):350-352. doi: 10.1080/13506129.2024.2404073. Epub 2024 Sep 16.
2
Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan.
J Neurol. 2018 Jan;265(1):134-140. doi: 10.1007/s00415-017-8640-7. Epub 2017 Nov 24.
3
CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings.
J Neurol Neurosurg Psychiatry. 2015 Feb;86(2):159-67. doi: 10.1136/jnnp-2014-308107. Epub 2014 Aug 4.
4
Therapeutic Potential of Polyamidoamine Dendrimer for Amyloidogenic Transthyretin Amyloidosis.
ACS Chem Neurosci. 2019 May 15;10(5):2584-2590. doi: 10.1021/acschemneuro.9b00059. Epub 2019 Mar 26.
5
Plasma neurofilament light chain: an early biomarker for hereditary ATTR amyloid polyneuropathy.
Amyloid. 2020 Jun;27(2):97-102. doi: 10.1080/13506129.2019.1708716. Epub 2020 Jan 6.
6
Diagnostic and prognostic contribution of DPD scintigraphy in transthyretin V30M cardiac amyloidosis.
Amyloid. 2024 Mar;31(1):32-41. doi: 10.1080/13506129.2023.2239987. Epub 2023 Jul 26.
7
Portuguese-type amyloidosis (transthyretin amyloidosis, ATTR V30M).
J Nephrol. 2003 May-Jun;16(3):438-42.
8
Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis.
Amyloid. 2013 Sep;20(3):142-50. doi: 10.3109/13506129.2013.797890. Epub 2013 May 28.
9
The relative amounts of plasma transthyretin forms in familial transthyretin amyloidosis: a quantitative analysis by Fourier transform ion-cyclotron resonance mass spectrometry.
Amyloid. 2011 Dec;18(4):191-9. doi: 10.3109/13506129.2011.614295.
10
Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
Life Sci. 2013 Dec 18;93(25-26):1017-22. doi: 10.1016/j.lfs.2013.10.031. Epub 2013 Nov 8.
引用本文的文献
1
Structural polymorphism of ALECT2 amyloid fibrils revealed by cryo-EM.
bioRxiv. 2025 Jul 18:2025.07.15.664973. doi: 10.1101/2025.07.15.664973.
2
Biomarkers in Subclinical Transthyretin Cardiac Amyloidosis.
Curr Heart Fail Rep. 2025 Feb 13;22(1):8. doi: 10.1007/s11897-025-00696-y.
本文引用的文献
1
Structure-Based Probe Reveals the Presence of Large Transthyretin Aggregates in Plasma of ATTR Amyloidosis Patients.
JACC Basic Transl Sci. 2024 Jul 17;9(9):1088-1100. doi: 10.1016/j.jacbts.2024.05.013. eCollection 2024 Sep.
2
Detection of Circulating Transthyretin Amyloid Aggregates in Plasma: A Novel Biomarker for Transthyretin Amyloidosis.
Circulation. 2024 May 21;149(21):1696-1699. doi: 10.1161/CIRCULATIONAHA.123.067225. Epub 2024 May 20.
3
Cardiac Amyloidosis Due to Transthyretin Protein: A Review.
JAMA. 2024 Mar 5;331(9):778-791. doi: 10.1001/jama.2024.0442.
4
The neuropathy in hereditary transthyretin amyloidosis: A narrative review.
J Peripher Nerv Syst. 2021 Jun;26(2):155-159. doi: 10.1111/jns.12451. Epub 2021 May 11.
5
A circulating, disease-specific, mechanism-linked biomarker for ATTR polyneuropathy diagnosis and response to therapy prediction.
Proc Natl Acad Sci U S A. 2021 Mar 2;118(9). doi: 10.1073/pnas.2016072118.
6
Peptide probes detect misfolded transthyretin oligomers in plasma of hereditary amyloidosis patients.
Sci Transl Med. 2017 Sep 13;9(407). doi: 10.1126/scitranslmed.aam7621.
Zotero 插件